tDCS for Cognitive Improvement in Healthy Subjects
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, affects thinking and memory skills in healthy individuals. It aims to understand the roles of different brain regions, such as the frontal and occipital areas, in tasks involving language, attention, and memory. Participants are divided into groups: some receive actual brain stimulation, while others undergo a placebo (fake) treatment. Suitable candidates have no history of head trauma and do not take psychiatric medications. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research on brain function and cognitive enhancement.
Do I need to stop my current medications for the trial?
The trial does not specify if you need to stop taking your current medications, but it excludes those with a history of treatment with psychotropic medication (drugs affecting mood, perception, or behavior).
What prior data suggests that transcranial direct current stimulation (tDCS) is safe for cognitive improvement studies?
Research has shown that transcranial direct current stimulation (tDCS) is generally safe and well-tolerated. Studies focusing on the dorsolateral prefrontal cortex (DLPFC) have found tDCS to be safe, with no serious side effects reported. This indicates it could be a promising method for treating various conditions without major safety concerns.
For stimulation of the occipital cortex, past research also supports its safety. The tDCS methods used in this trial mirror those in previous studies, which have not resulted in serious adverse effects. Some minor effects, like skin irritation, might occur but are not considered serious.
Overall, evidence suggests that tDCS, when used as described in similar studies, is safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about transcranial direct current stimulation (tDCS) because it offers a non-invasive way to potentially boost cognitive function by using low-level electrical currents. Unlike traditional cognitive enhancers that rely on medication, tDCS directly targets brain areas like the dorsolateral prefrontal cortex and the occipital cortex to modulate neural activity. This approach could offer a safer alternative with fewer side effects compared to drugs, and it might provide quicker results. By exploring different stimulation sites, like the DLPFC and occipital cortex, researchers hope to better understand and maximize the cognitive benefits of tDCS.
What evidence suggests that transcranial direct current stimulation (tDCS) is effective for cognitive improvement?
Research has shown that transcranial direct current stimulation (tDCS) can improve thinking skills. In this trial, participants may receive stimulation targeting the dorsolateral prefrontal cortex (DLPFC), which previous studies have shown can significantly enhance cognitive abilities, especially with higher electrical currents. One study revealed that 68.6% of participants who received active tDCS reported better cognitive performance, compared to 31.4% in the group that received a sham treatment.
This trial also includes an arm where participants receive stimulation at the back of the brain, specifically the occipital cortex. Research suggests that tDCS in this area can boost overall thinking abilities, as seen in conditions like mild cognitive impairment and Alzheimer's disease. It may also aid in cognitive training for conditions like schizophrenia. Overall, tDCS shows promise in improving brain functions related to thinking and memory.678910Are You a Good Fit for This Trial?
This trial is for healthy individuals aged 18-50 who speak and understand English well enough to complete cognitive tasks. They must be able to consent to the study. People with head trauma, psychotropic medication use, poor vision without correction, or conditions that contraindicate tDCS/MRI (like pregnancy or metal in the body) cannot participate.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex or occipital cortex, or sham stimulation
Follow-up
Participants are monitored for cognitive performance using behavioral and electrophysiological measures
What Are the Treatments Tested in This Trial?
Interventions
- Transcranial Direct Current Stimulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Davis
Lead Sponsor